메뉴 건너뛰기




Volumn 12, Issue 2, 2010, Pages 134-139

Evidence for aggressive blood pressure-lowering goals in patients with coronary artery disease

Author keywords

Blood pressure; BP goals; Coronary artery disease; Hypertension; J curve

Indexed keywords

ANTIHYPERTENSIVE AGENT;

EID: 77953538600     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-010-0094-7     Document Type: Review
Times cited : (9)

References (40)
  • 1
    • 0037516558 scopus 로고    scopus 로고
    • High blood pressure in the community
    • Epidemiology of Hypertension. Edited by Bulpitt CJ. Amsterdam: Elsevier Science
    • Elliott P: High blood pressure in the community. In Handbook of Hypertension, vol 20. Epidemiology of Hypertension. Edited by Bulpitt CJ. Amsterdam: Elsevier Science; 2000:1-18.
    • (2000) Handbook of Hypertension , pp. 1-18
    • Elliott, P.1
  • 2
    • 0034610803 scopus 로고    scopus 로고
    • The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven countries study research group
    • van den Hoogen PC, Feskens EJ, Nagelkerke NJ, et al.: The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group. N Engl J Med 2000, 342:1-8.
    • (2000) N Engl J Med , vol.342 , pp. 1-8
    • Van Den Hoogen, P.C.1    Feskens, E.J.2    Nagelkerke, N.J.3
  • 3
    • 0347423198 scopus 로고    scopus 로고
    • Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure
    • Chobanian AV, Bakris GL, Black HR, et al.: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42:1406-11252
    • (2003) Hypertension , vol.42 , pp. 1406-11252
    • Chobanian, A.V.1    Bakris, G.L.2    Black, H.R.3
  • 4
    • 34249655660 scopus 로고    scopus 로고
    • Treatment of hypertension in the prevention and management of ischemic heart disease. A scientific statement from the American heart association council for high blood pressure research and the councils on clinical cardiology and epidemiology and prevention
    • This is a comprehensive review of the management of hypertension to prevent the development of coronary heart disease, as well as a review of hypertension management in those patients with established coronary disease. The statement provides evidence and guidance on lowering BP in these patient populations
    • Rosendorff C, Black HR, Cannon CP, et al.: Treatment of hypertension in the prevention and management of ischemic heart disease. A Scientific Statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation 2007, 115:2761-2788. This is a comprehensive review of the management of hypertension to prevent the development of coronary heart disease, as well as a review of hypertension management in those patients with established coronary disease. The statement provides evidence and guidance on lowering BP in these patient populations.
    • (2007) Circulation , vol.115 , pp. 2761-2788
    • Rosendorff, C.1    Black, H.R.2    Cannon, C.P.3
  • 5
    • 52949116801 scopus 로고    scopus 로고
    • Nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular disease
    • Steinberg BA, Bhatt DL, Mehta S, et al.: Nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular disease. Am Heart J 2008, 156:719-727.
    • (2008) Am Heart J , vol.156 , pp. 719-727
    • Steinberg, B.A.1    Bhatt, D.L.2    Mehta, S.3
  • 6
    • 4444252228 scopus 로고    scopus 로고
    • Mechanisms and management of hypertensive heart disease: From left ventricular hypertrophy to heart failure
    • Izzo JL Jr, Gradman AH: Mechanisms and management of hypertensive heart disease: from left ventricular hypertrophy to heart failure. Med Clin North Am 2004, 88:1257-1270.
    • (2004) Med Clin North Am , vol.88 , pp. 1257-1270
    • Izzo Jr., J.L.1    Gradman, A.H.2
  • 7
    • 0023148115 scopus 로고
    • Metabolic control of coronary blood flow
    • Olsson RA, Bünger R: Metabolic control of coronary blood flow. Prog Cardiovasc Dis 1987, 29:369-387.
    • (1987) Prog Cardiovasc Dis , vol.29 , pp. 369-387
    • Olsson, R.A.1    Bünger, R.2
  • 8
    • 0023689115 scopus 로고
    • Coronary pressure-function and steady-state pressure-flow relations during autoregulation in the unanesthetized dog
    • Canty JM Jr: Coronary pressure-function and steady-state pressure-flow relations during autoregulation in the unanesthetized dog. Circ Res 1988, 63:821-836.
    • (1988) Circ Res , vol.63 , pp. 821-836
    • Canty Jr., J.M.1
  • 9
    • 0036732776 scopus 로고    scopus 로고
    • Angiotensin inhibition and coronary autoregulation in a canine model of LV hypertrophy
    • Rouleau JR, Simard D, Blouin A, et al.: Angiotensin inhibition and coronary autoregulation in a canine model of LV hypertrophy. Basic Res Cardiol 2002, 97:384-391.
    • (2002) Basic Res Cardiol , vol.97 , pp. 384-391
    • Rouleau, J.R.1    Simard, D.2    Blouin, A.3
  • 10
    • 0021952889 scopus 로고
    • Reduced regional myocardial perfusion in the presence of pharmacologic vasodilator reserve
    • Canty JM Jr, Klocke FJ: Reduced regional myocardial perfusion in the presence of pharmacologic vasodilator reserve. Circulation 1985, 71:370-1337
    • (1985) Circulation , vol.71 , pp. 370-1337
    • Canty Jr., J.M.1    Klocke, F.J.2
  • 11
    • 3142776074 scopus 로고
    • Cardiac hypertrophy in hypertension. Repolarization abnormalities elicited by rapid lowering of pressure
    • Pepi M, Alimento M, Maltagliati A, Guazzi MD: Cardiac hypertrophy in hypertension. Repolarization abnormalities elicited by rapid lowering of pressure. Hypertension 1988, 11:84-91.
    • (1988) Hypertension , vol.11 , pp. 84-91
    • Pepi, M.1    Alimento, M.2    Maltagliati, A.3    Guazzi, M.D.4
  • 12
    • 0019987560 scopus 로고
    • Coronary blood flow in left ventricular hypertrophy: A review of experimental data
    • Wicker P, Tarazi RC: Coronary blood flow in left ventricular hypertrophy: a review of experimental data. Eur Heart J 1982, 3 (Suppl A):111-118.
    • (1982) Eur Heart J , vol.3 , Issue.SUPPL. A , pp. 111-118
    • Wicker, P.1    Tarazi, R.C.2
  • 13
    • 34547927560 scopus 로고    scopus 로고
    • Beneficial effects of valsartan in asymptomatic individuals with vascular or cardiac abnormalities-The DETECTIV pilot study
    • Duprez DA, Florea ND, Jones K, et al.: Beneficial effects of valsartan in asymptomatic individuals with vascular or cardiac abnormalities-the DETECTIV pilot study. J Am Coll Cardiol 2007, 50:835-839.
    • (2007) J Am Coll Cardiol , vol.50 , pp. 835-839
    • Duprez, D.A.1    Florea, N.D.2    Jones, K.3
  • 14
    • 33746797303 scopus 로고    scopus 로고
    • Effects of normal, prehypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosis
    • Sipahi I, Tuzcu EM, Schoenhagen P, et al.: Effects of normal, prehypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosis. J Am Coll Cardiol 2006, 48: 833-838.
    • (2006) J Am Coll Cardiol , vol.48 , pp. 833-838
    • Sipahi, I.1    Tuzcu, E.M.2    Schoenhagen, P.3
  • 15
    • 41949101956 scopus 로고    scopus 로고
    • Effect of lower targets for blood pressure and ldl cholesterol on atherosclerosis in diabetes: The SANDS randomized trial
    • This study shows that aggressive BP and lipid lowering resulted in regression of carotid IMT and a significant decrease in left ventricular mass in Native Americans
    • Howard BV, Roman MJ, Devereux RB, et al.: Effect of lower targets for blood pressure and ldl cholesterol on atherosclerosis in diabetes: the SANDS randomized trial. JAMA 2008, 299:1678-1689. This study shows that aggressive BP and lipid lowering resulted in regression of carotid IMT and a significant decrease in left ventricular mass in Native Americans.
    • (2008) JAMA , vol.299 , pp. 1678-1689
    • Howard, B.V.1    Roman, M.J.2    Devereux, R.B.3
  • 16
    • 68349131420 scopus 로고    scopus 로고
    • Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): An open-label randomised trial
    • Verdecchia P, Staessen JA, Angeli F, et al.: Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial. Lancet 2009, 374:525-533.
    • (2009) Lancet , vol.374 , pp. 525-533
    • Verdecchia, P.1    Staessen, J.A.2    Angeli, F.3
  • 17
    • 0025831464 scopus 로고
    • Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the systolic hypertension in the elderly program
    • SHEP Cooperative Research Group
    • SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the Systolic Hypertension in the Elderly Program. JAMA 1991, 265:3255-3264.
    • (1991) JAMA , vol.265 , pp. 3255-3264
  • 18
    • 0343487983 scopus 로고    scopus 로고
    • Randomised doubleblind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The systolic hypertension in Europe (Syst-Eur) trial investigators
    • Staessen JA, Fagard R, Lutgarde T, et al.: Randomised doubleblind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997, 350:757-764.
    • (1997) Lancet , vol.350 , pp. 757-764
    • Staessen, J.A.1    Fagard, R.2    Lutgarde, T.3
  • 19
    • 0031769003 scopus 로고    scopus 로고
    • Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic hypertension in China (Syst-China) collaborative group
    • Liu L, Wang JG, Gong L, et al.: Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group. J Hypertens 1998, 16:1823-1829.
    • (1998) J Hypertens , vol.16 , pp. 1823-1829
    • Liu, L.1    Wang, J.G.2    Gong, L.3
  • 20
    • 0032513878 scopus 로고    scopus 로고
    • Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
    • DOI 10.1016/S0140-6736(98)04311-6
    • Hansson L, Zanchetti A, Carruthers SG, et al.: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998, 351:1755-1762. (Pubitemid 28269185)
    • (1998) Lancet , vol.351 , Issue.9118 , pp. 1755-1762
    • Hansson, L.1    Zanchetti, A.2    Carruthers, S.G.3    Dahlof, B.4    Elmfeldt, D.5    Julius, S.6    Menard, J.7    Rahn, K.H.8    Wedel, H.9    Westerling, S.10
  • 21
    • 0032485350 scopus 로고    scopus 로고
    • The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin dependent diabetes and hypertension
    • Estacio R, Jeffers B, Hiatt W, et al.: The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin dependent diabetes and hypertension. N Engl J Med 1998, 338:645-652.
    • (1998) N Engl J Med , vol.338 , pp. 645-652
    • Estacio, R.1    Jeffers, B.2    Hiatt, W.3
  • 22
    • 0032511601 scopus 로고    scopus 로고
    • Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
    • UK Prospective Diabetes Study Group
    • UK Prospective Diabetes Study Group: Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ 1998, 317:713-720.
    • (1998) BMJ , vol.317 , pp. 713-720
  • 23
    • 0035522330 scopus 로고    scopus 로고
    • Impact of high-normal blood pressure on the risk of cardiovascular disease
    • Vasan RS, Larson MG, Leip EP, et al.: Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001, 345:1291-1297
    • (2001) N Engl J Med , vol.345 , pp. 1291-1297
    • Vasan, R.S.1    Larson, M.G.2    Leip, E.P.3
  • 24
    • 33846857345 scopus 로고    scopus 로고
    • Effects of normal blood pressure, prehypertension, and hypertension on coronary microvascular function
    • Erdogan D, Yildirim I, Ciftci O, et al.: Effects of normal blood pressure, prehypertension, and hypertension on coronary microvascular function. Circulation 2007, 115:593-599.
    • (2007) Circulation , vol.115 , pp. 593-599
    • Erdogan, D.1    Yildirim, I.2    Ciftci, O.3
  • 25
    • 0037079309 scopus 로고    scopus 로고
    • Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies
    • Prospective Studies Collaboration
    • Lewington S, Clarke R, Qizilbash N, et al.; Prospective Studies Collaboration: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903-1913.
    • (2002) Lancet , vol.360 , pp. 1903-1913
    • Lewington, S.1    Clarke, R.2    Qizilbash, N.3
  • 26
    • 0023734590 scopus 로고
    • Coronary flow reserve and the J curve relation between diastolic blood pressure and myocardial infarction
    • Cruickshank JM.: Coronary flow reserve and the J curve relation between diastolic blood pressure and myocardial infarction. BMJ 1988, 297:1227-1230.
    • (1988) BMJ , vol.297 , pp. 1227-1230
    • Cruickshank, J.M.1
  • 27
    • 0023122783 scopus 로고
    • Benefits and potential harm of lowering high blood pressure
    • Cruickshank JM, Thorp JM, Zacharias FJ: Benefits and potential harm of lowering high blood pressure. Lancet 1987, 1:581-584.
    • (1987) Lancet , vol.1 , pp. 581-584
    • Cruickshank, J.M.1    Thorp, J.M.2    Zacharias, F.J.3
  • 28
    • 0033610261 scopus 로고    scopus 로고
    • The role of diastolic blood pressure when treating isolated systolic hypertension
    • Somes GW, Pahor M, Shorr RI, et al.: The role of diastolic blood pressure when treating isolated systolic hypertension. Arch Intern Med 1999, 159:2004-2009.
    • (1999) Arch Intern Med , vol.159 , pp. 2004-2009
    • Somes, G.W.1    Pahor, M.2    Shorr, R.I.3
  • 29
    • 34250333736 scopus 로고    scopus 로고
    • On-treatment diastolic blood pressure and prognosis in systolic hypertension
    • Fagard R, Staessen J, Thijs L, et al.: On-treatment diastolic blood pressure and prognosis in systolic hypertension. Arch Intern Med 2007, 167:1884-1891.
    • (2007) Arch Intern Med , vol.167 , pp. 1884-1891
    • Fagard, R.1    Staessen, J.2    Thijs, L.3
  • 30
    • 0345492460 scopus 로고    scopus 로고
    • A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease
    • The International Verapamil-Trandolapril Study (INVEST): A randomized controlled trial
    • Pepine CJ, Handberg EM, Cooper-DeHoff RM, et al.: A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. JAMA 2003, 290:2805-2816.
    • (2003) JAMA , vol.290 , pp. 2805-2816
    • Pepine, C.J.1    Handberg, E.M.2    Cooper-DeHoff, R.M.3
  • 31
    • 33745295923 scopus 로고    scopus 로고
    • Dogma disputed: Can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?
    • Messerli F, Mancia G, Conti R, et al.: Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med 2006, 144:884-893.
    • (2006) Ann Intern Med , vol.144 , pp. 884-893
    • Messerli, F.1    Mancia, G.2    Conti, R.3
  • 32
    • 0037133549 scopus 로고    scopus 로고
    • J-shaped relationship between blood pressure and mortality in hypertensive patients: New insights from a meta-analysis of individual-patient data
    • Boutitie F, Gueyffier F, Pocock S, et al.: J-shaped relationship between blood pressure and mortality in hypertensive patients: new insights from a meta-analysis of individual-patient data. Ann Intern Med 2002, 136:438-448.
    • (2002) Ann Intern Med , vol.136 , pp. 438-448
    • Boutitie, F.1    Gueyffier, F.2    Pocock, S.3
  • 33
    • 70349695998 scopus 로고    scopus 로고
    • Relationship between the achieved blood pressure and the incidence of cardiovascular events in Japanese hypertensive patients with complications: A sub-analysis of the CASE-J trial
    • Ogihara T, Saruta T, Rakugi H, et al.: Relationship between the achieved blood pressure and the incidence of cardiovascular events in Japanese hypertensive patients with complications: a sub-analysis of the CASE-J trial. Hypertension Research 2009, 32:248-254.
    • (2009) Hypertension Research , vol.32 , pp. 248-254
    • Ogihara, T.1    Saruta, T.2    Rakugi, H.3
  • 34
    • 34250819387 scopus 로고    scopus 로고
    • Diastolic blood pressure and mortality in the elderly with cardiovascular disease
    • Protogerou A, Safar M, Iaria P, et al.: Diastolic blood pressure and mortality in the elderly with cardiovascular disease. Hypertension 2007, 50:172-180.
    • (2007) Hypertension , vol.50 , pp. 172-180
    • Protogerou, A.1    Safar, M.2    Iaria, P.3
  • 35
    • 27744542905 scopus 로고    scopus 로고
    • Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan diabetic nephropathy trial
    • Berl T, Hunsicker LG, Lewis JB, et al: Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial. J Am Soc Nephrol 2005, 16:2170-2179.
    • (2005) J Am Soc Nephrol , vol.16 , pp. 2170-2179
    • Berl, T.1    Hunsicker, L.G.2    Lewis, J.B.3
  • 36
    • 0037157096 scopus 로고    scopus 로고
    • Pulse pressure and cardiovascular disease related mortality: Follow-up study of the multiple risk factor intervention trial (MRFIT)
    • Domanski M, Mitchell G, Pfeffer M, et al.: Pulse pressure and cardiovascular disease related mortality: follow-up study of the Multiple Risk factor Intervention Trial (MRFIT). JAMA 2002, 287:2677-2683.
    • (2002) JAMA , vol.287 , pp. 2677-2683
    • Domanski, M.1    Mitchell, G.2    Pfeffer, M.3
  • 37
    • 0028318733 scopus 로고
    • Optimal blood pressure control in treated hypertensive patients. Report from the department of health hypertension care computing project (DHCCP)
    • Bulpitt CJ, Palmer AJ, Fletcher AE, et al.: Optimal blood pressure control in treated hypertensive patients. Report from the Department of Health Hypertension Care Computing Project (DHCCP). Circulation 1994, 90:225-233.
    • (1994) Circulation , vol.90 , pp. 225-233
    • Bulpitt, C.J.1    Palmer, A.J.2    Fletcher, A.E.3
  • 39
    • 0031688761 scopus 로고    scopus 로고
    • Low diastolic blood pressure and mortality in a population-based cohort of 16 913 hypertensive patients in North Karelia, Finland
    • Tuomilehto J, Ryynänen OP, Koistinen A, et al.: Low diastolic blood pressure and mortality in a population-based cohort of 16 913 hypertensive patients in North Karelia, Finland. J Hypertens 1998, 16:1235-1242.
    • (1998) J Hypertens , vol.16 , pp. 1235-1242
    • Tuomilehto, J.1    Ryynänen, O.P.2    Koistinen, A.3
  • 40
    • 34250730722 scopus 로고    scopus 로고
    • Rationale and design for the blood pressure intervention of the action to control cardiovascular risk in diabetes (ACCORD) trial
    • The BP arm of the ACCORD trial is testing the hypothesis that aggressive treatment of hypertension in type 2 diabetes by lowering BP to lower targets will improve outcomes
    • Cushman WC, Grimm RH Jr, Cutler JA, et al.: Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol 2007, 99:44i-55i. The BP arm of the ACCORD trial is testing the hypothesis that aggressive treatment of hypertension in type 2 diabetes by lowering BP to lower targets will improve outcomes.
    • (2007) Am J Cardiol , vol.99
    • Cushman, W.C.1    Grimm Jr., R.H.2    Cutler, J.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.